Peritoneal Mesothelioma 2024: Latest Treatments & Survivor Insights
July 16, 2024
Time: 6:00 p.m. ET
Learn about the latest advances in peritoneal mesothelioma treatment during our upcoming webinar exclusively for patients and their families. Dr. Edward Levine, a nationally recognized HIPEC specialist, will discuss the newest developments in treating peritoneal cancer, and 17-year mesothelioma survivor Tamron Little will share her journey from diagnosis to today.
Join our webinar on the latest peritoneal mesothelioma treatments exclusively for patients and families. Dr. Levine, a top HIPEC specialist, will share insights on new treatment developments, and 17-year survivor Tamron Little will share her journey.
-
Edward Levine, MDSurgical Oncologist and Peritoneal Specialist -
Tamron Little17-Year Peritoneal Mesothelioma Survivor -
Sean Marchese, MS, RNOncology Medical Writer and Registered Nurse
What You’ll Learn During the Webinar
- Top peritoneal mesothelioma treatment options
- New approaches to treating peritoneal mesothelioma
- Clinical trials for peritoneal mesothelioma patients
- Insight from a peritoneal mesothelioma survivor on the physical and mental effects of treatment
Our experts will answer your questions during a live Q&A at the end of the presentation.
Looking for information on pleural mesothelioma instead? Sign up for our upcoming pleural mesothelioma session.
Mesothelioma Experts You Can Trust
Dr. Levine and Tamron Little have spent years helping mesothelioma patients and their families. They know the ins and outs of mesothelioma treatment, and they’ve stayed up to date with the latest research for peritoneal patients.-
Edward Levine, MDDr. Edward Levine is the chief of surgical oncology services at the Wake Forest Baptist Health Comprehensive Cancer Center in Winston-Salem, North Carolina. He is nationally renowned for his use of HIPEC and cytoreductive surgery for peritoneal surface malignancies. -
Tamron LittleTamron Little was diagnosed with peritoneal mesothelioma in 2007 at age 21. She underwent successful surgery, HIPEC and radiation therapy. After nearly two decades of surviving with mesothelioma, Tamron shares her experiences to support people diagnosed with this rare cancer. -
Sean Marchese, MS, RNAs a registered nurse with more than 20 years in clinical experience and more than six years in clinical research, Sean Marchese has planned and led oncology clinical trials involving immunotherapy, chemotherapy, radiation therapy and tumor treating fields. He has been a member of the American Nurses Association since 2017.
